A significant breakthrough in cancer study is arising with the use of VHH fragments to restore mutated p53. This essential tumor protector protein is frequently inactivated in various forms of tumors, resulting https://bookmarksusa.com/story22028757/mini-antibodies-revive-the-p53-protein-the-new-pathway-for-malignant-therapy